bimekizumab,izokibep
moonlake,ucb biopharma,acelyrin
['izokibep', 'be heard i', 'bimzelx', ' hs ', '$mltx']
worst case scenario for $mltx's slk (il-17a/f nanobody) at #aad2023 this weekend: bimzelx (il-17a/f mab) significantly underwhelmed vs expectations in hs on hiscr50/hiscr75. izokibep (il-17a small kda mab) results are ambiguous due to more mild patients enrolled. 